Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AN2 Therapeutics, Inc. | 0 | reported | 19 Mar 2026 | tx 18+564,765−403,729 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 82,300 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 66,000 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 66,000 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 73,665 | — | deriv |
| 19 Mar 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 73,665 | — | deriv |
| 19 Mar 2026 | OTHER | AN2 Therapeutics, Inc. | 82,300 | — | deriv |
| 20 Feb 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 38,000 | 0.00 USD | |
| 20 Feb 2026 | GRANT_AWARD | AN2 Therapeutics, Inc. | 77,000 | 0.00 USD | deriv |
| 05 Jan 2026 | SALE | AN2 Therapeutics, Inc. | 3,295 | 1.00 USD | |
| 06 Jan 2026 | SALE | AN2 Therapeutics, Inc. | 5,512 | 1.01 USD | |
| 26 Feb 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 46,500 | 0.00 USD | |
| 26 Feb 2025 | GRANT_AWARD | AN2 Therapeutics, Inc. | 93,000 | 0.00 USD | deriv |
| 03 Jan 2025 | SALE | AN2 Therapeutics, Inc. | 2,957 | 1.34 USD | |
| 15 Mar 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 27,500 | 0.00 USD | |
| 15 Mar 2024 | GRANT_AWARD | AN2 Therapeutics, Inc. | 55,000 | 0.00 USD | deriv |
| 15 Feb 2023 | GRANT_AWARD | AN2 Therapeutics, Inc. | 82,300 | 0.00 USD | deriv |
| 12 May 2022 | GRANT_AWARD | AN2 Therapeutics, Inc. | 66,000 | 0.00 USD | deriv |